A possible treatment approach to IHD is anti-inflammation in coronary artery [112], as illustrated by studies on IL-1β as a therapeutic target for the treatment of atherosclerotic vascular disease [113,114]. The gene discussed is IL1B; the disease is myocardial ischemia.